Sotwe logo Sotwe logo

Top Tweets for #vps20

realovirtualcom's profile image
Real o Virtual @realovirtualcom
Niantic Spatial impulsa el mapeo 3D con Scaniverse y VPS 2.0 https://t.co/M7mcCbJYyg @NianticSpatial #Scaniverse #VPS20
0
3
0
0
160
ASCOPost's profile image
The ASCO Post @ASCOPost
Marina C. Garassino, MD, on COVID-19 and Thoracic Malignancies: TERAVOLT Registry https://t.co/G0l5TxEqDY #LCSM #COVID19 #WCLC2020 #VPS20 @IASLC @IstTumori
ASCOPost's tweet photo. Marina C. Garassino, MD, on COVID-19 and Thoracic Malignancies: TERAVOLT Registry https://t.co/G0l5TxEqDY #LCSM #COVID19 #WCLC2020 #VPS20 @IASLC @IstTumori https://t.co/8kbCsgQrNI
0
2
2
0
0
ASCOPost's profile image
The ASCO Post @ASCOPost
Misako Nagasaka, MD, on NSCLC: Sintilimab, Pemetrexed, and Platinum as First-Line Therapy https://t.co/ALGtRHjSdB #LCSM #WCLC2020 #VPS20 @karmanoscancer
ASCOPost's tweet photo. Misako Nagasaka, MD, on NSCLC: Sintilimab, Pemetrexed, and Platinum as First-Line Therapy https://t.co/ALGtRHjSdB #LCSM #WCLC2020 #VPS20 @karmanoscancer https://t.co/Q7RNQXzASl
1
6
1
0
0
IASLC's profile image
IASLC Verified account @IASLC
A big THANK YOU to all who donated to the ILCF during registration for #VPS20. Together, we surpassed our goal & raised USD $7,940. All donations support innovative research that inspires hope for thousands of patients living with #lungcancer. #LCSM https://t.co/Ml6O9oPHv7
IASLC's tweet photo. A big THANK YOU to all who donated to the ILCF during registration for #VPS20. Together, we surpassed our goal & raised USD $7,940. All donations support innovative research that inspires hope for thousands of patients living with #lungcancer. #LCSM https://t.co/Ml6O9oPHv7 https://t.co/EJl6WpCDpz
0
11
2
0
0
StephenVLiu's profile image
Stephen V Liu, MD Verified account @StephenVLiu
Great @BTOGORG webinar. Treat to hear expert @fblackhall discuss #ALK updates from @IASLC #VPS20. Caution not to read too much into intracranial RR differences with ensartinib due to low numbers. Many excellent next gen ALK TKIs - note their different toxicity profiles. #LCSM
StephenVLiu's tweet photo. Great @BTOGORG webinar. Treat to hear expert @fblackhall discuss #ALK updates from @IASLC #VPS20. Caution not to read too much into intracranial RR differences with ensartinib due to low numbers. Many excellent next gen ALK TKIs - note their different toxicity profiles. #LCSM https://t.co/xHfO0jdeqH
1
11
7
2
0
OncLive's profile image
OncLive.com Verified account @OncLive
Nivolumab plus ipilimumab significantly improved OS versus chemotherapy in the first-line treatment of patients with unresectable malignant pleural mesothelioma. @NKI_nl @IASLC #VPS20 #lcsm https://t.co/kS4yPHffO6
0
3
2
0
0
OncLive's profile image
OncLive.com Verified account @OncLive
Ensartinib showed a significant improvement in PFS over crizotinib with a favorable safety profile in patients with ALK-positive NSCLC. @VUMC_Cancer @IASLC #VPS20 #lcsm https://t.co/RQUA69lVx2
0
2
1
0
0
OncLive's profile image
OncLive.com Verified account @OncLive
Sintilimab injection plus pemetrexed & platinum-based therapy led to a statistically significant improvement in PFS compared w/ chemo alone as a first-line treatment for patients w/ locally advanced or metastatic nonsquamous NSCLC. @IASLC #VPS20 #lcsm https://t.co/4LpsHo37Nc
0
2
1
0
0
IASLC's profile image
IASLC Verified account @IASLC
Great coverage by @medpagetoday of Dr. Leora Horn's abstract Phase 3 Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK)–Positive NSCLC Patients: eXalt3 presented at #VPS20. Read more below! https://t.co/45c2hsm6Wz #LCSM #VPS20 #WCLC2020
0
19
8
0
0
IASLC's profile image
IASLC Verified account @IASLC
Great coverage by @medpagetoday of First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743 presented by Dr. Paul Baas at the Virtual Presidential Symposium. Read more below! #VPS20 #WCLC2020 https://t.co/I0c9AWCozZ
0
11
5
0
0
brunolarvol's profile image
ONCO BRUNO Verified account @brunolarvol
🟣🟣🟣🐯#OncVoice eXalt3 phase 3⃣ trial data at #VPS20 - ensartinib vs crizotinib πŸ’Šin #ALK–positive #NSCLC (ensartinib improves PFS vs Crizo) See reactions from top oncologists πŸ‘πŸ‘Ž @StephenVLiu @APassaroMD @bensolomon1 List with tweet links: https://t.co/yoFvpqvhFP
brunolarvol's tweet photo. 🟣🟣🟣🐯#OncVoice eXalt3 phase 3⃣ trial data at #VPS20 - ensartinib vs crizotinib πŸ’Šin #ALK–positive #NSCLC (ensartinib improves PFS vs Crizo) See reactions from top oncologists πŸ‘πŸ‘Ž @StephenVLiu @APassaroMD @bensolomon1 List with tweet links: https://t.co/yoFvpqvhFP https://t.co/oXq0cPdVAM
0
6
2
0
0
brunolarvol's profile image
ONCO BRUNO Verified account @brunolarvol
🟣🟣🟣🐯#OncVoice ORIENT-11 phase 3⃣ study data #VPS20 #Sintilimab + platinum/pemetrexed in #NSCLC View reactions from top oncologists πŸ‘πŸ‘Ž @NarjustDumaMD @StephenVLiu @DevikaDasMD @passaromd List with tweet links: https://t.co/1Z8azhnQKu Trial link: https://t.co/n8vHReWs5C
brunolarvol's tweet photo. 🟣🟣🟣🐯#OncVoice ORIENT-11 phase 3⃣ study data #VPS20 #Sintilimab + platinum/pemetrexed in #NSCLC View reactions from top oncologists πŸ‘πŸ‘Ž @NarjustDumaMD @StephenVLiu @DevikaDasMD @passaromd List with tweet links: https://t.co/1Z8azhnQKu Trial link: https://t.co/n8vHReWs5C https://t.co/R8uLkOZR8k
0
5
2
0
0
DrewMoghanaki's profile image
Drew Moghanaki Verified account @DrewMoghanaki
Below is a list of ongoing clinical trials for lung cancer that are sponsored by Bristol-Myers Squibb. The bar on the right indicates what phase it's in. #lcsm #lcam #ASCO20 #VPS20 #WCLC20 @IASLC
DrewMoghanaki's tweet photo. Below is a list of ongoing clinical trials for lung cancer that are sponsored by Bristol-Myers Squibb. The bar on the right indicates what phase it's in. #lcsm #lcam #ASCO20 #VPS20 #WCLC20 @IASLC https://t.co/U3cFKl8Vca
0
15
5
3
0
OncLive's profile image
OncLive.com Verified account @OncLive
Ensartinib Significantly Prolongs PFS Over Crizotinib in ALK+ NSCLC @VUMC_Cancer @IASLC #VPS20 #lcsm https://t.co/foR4Bb0eRM
0
2
0
0
0
BrendonStilesMD's profile image
Brendon Stiles @BrendonStilesMD
One of my @lcrf_org favorite events of the year is now virtual today. Starting at 9. Take a break from #ASCO20 and #vps20 to join us and support lung cancer research. #lcsm https://t.co/rLS7LMEIyl
BrendonStilesMD's tweet photo. One of my @lcrf_org favorite events of the year is now virtual today. Starting at 9. Take a break from #ASCO20 and #vps20 to join us and support lung cancer research. #lcsm https://t.co/rLS7LMEIyl https://t.co/p9BGQBZeTB
2
39
4
0
0
OncoAlert's profile image
OncoAlert Verified account @OncoAlert
Our Awesome @OncoAlert 🚨colleague @marinagarassino "Patients with Thoracic tumors are at higher risk from #COVID19 " #LCSM #LungCancer #VPS20 #WCLC20 #ASCO20
IASLC's profile image
IASLC Verified account @IASLC
Dr. @MarinaGarassino says patients with thoracic tumors are higher risk from #COVID19, esp. considering comorbidities, age & tumors located in the thorax. This is true when compared with the gen. population but with other cancer types. https://t.co/nATT2bGgBM #VPS20 #LCSM #WCLC20
IASLC's tweet photo. Dr. @MarinaGarassino says patients with thoracic tumors are higher risk from #COVID19, esp. considering comorbidities, age & tumors located in the thorax. This is true when compared with the gen. population but with other cancer types. https://t.co/nATT2bGgBM #VPS20 #LCSM #WCLC20 https://t.co/mu1sAA9UOx
0
30
8
0
0
0
8
2
0
0
weoncologists's profile image
Gil Morgan, MD Verified account @weoncologists
Great slide from #VPS20 #WCLC20 yesterday by our AMAZING @OncoAlert 🚨colleague @christine_lovly Tweet by our other awesome OncoAlert Colleague @APassaroMD Wanted to share with #ASCO20 A summary of Next Generation ALK TKI trials vs. crizotinib #LCSM #LungCancer @OncoAlert 🚨
APassaroMD's profile image
AɴᴛᴏɴΙͺᴏ Pα΄€ssᴀʀᴏ Verified account @APassaroMD
Very exhaustive summary by @christine_lovly discussing the eXalt3 results. Here a focus on next-gen ALK TKIs results vs Crizotinib, waiting for CROWN results investigating #lorlatinib in the same #setting #VPS20 #LCSM #WCLC20
APassaroMD's tweet photo. Very exhaustive summary by @christine_lovly discussing the eXalt3 results. Here a focus on next-gen ALK TKIs results vs Crizotinib, waiting for CROWN results investigating #lorlatinib in the same #setting #VPS20 #LCSM #WCLC20 https://t.co/CdE1SolGwl
1
50
20
6
0
0
16
7
0
0
Biotech2050's profile image
Emmanuele Verified account @Biotech2050
$BMY #asbestos CheckMate-743 #VPS20
0
1
0
0
0
Latinamd's profile image
Dr. Estela Rodriguez Verified account @Latinamd
Woke up early to watch the virtual presentation of #Checkmate743. International Phase 3 trial of Ipi/Nivo vs Chemo in unresectable #mesothelioma. New standard w/ (HR 0.74) 2yr survival 41% vs 27%, trend of improved benefit for PDL1>1% @IASLC #WCLC20 #VPS20 #lcsm
Latinamd's tweet photo. Woke up early to watch the virtual presentation of #Checkmate743. International Phase 3 trial of Ipi/Nivo vs Chemo in unresectable #mesothelioma. New standard w/ (HR 0.74) 2yr survival 41% vs 27%, trend of improved benefit for PDL1>1% @IASLC #WCLC20 #VPS20 #lcsm https://t.co/s8DWK6tXQw
0
23
7
1
0
Latinamd's profile image
Dr. Estela Rodriguez Verified account @Latinamd
Excellent virtual discussion by @MNagasaka @iaslc #WCLC20 #VPS20 #ORIENT11 #sintilimab IO+chemo for #lungcancer. -Another option for 1st line chemo+IO -Similar outcomes to KN189 but need more follow up. -Study based on Asian population, w more never smokers. #lcsm
Latinamd's tweet photo. Excellent virtual discussion by @MNagasaka @iaslc #WCLC20 #VPS20 #ORIENT11 #sintilimab IO+chemo for #lungcancer. -Another option for 1st line chemo+IO -Similar outcomes to KN189 but need more follow up. -Study based on Asian population, w more never smokers. #lcsm https://t.co/qCZrsuqQNL
0
4
0
0
0

Last Seen Hashtags on Sotwe

incesto madre
Seen from Mexico
ΰΈ£ΰΈ±ΰΈšΰΈ‡ΰΈ²ΰΈ™ΰΉ€ΰΈ„ΰΈ£ΰΈ·ΰΈ­ΰΈͺΰΈ«ΰΈžΰΈ±ΰΈ’ΰΈ™ΰΉŒ
Seen from Thailand
momsonn
Seen from Brazil
littlesister
Seen from United States
γ‚«γƒ­γ‚Ή
Seen from Colombia
brosis
Seen from United Kingdom
candid()
Seen from Canada
εŒ—ζ–—5
Seen from United States
醉ε₯Έ
Seen from United Kingdom
latina
Seen from United States

Trends for you

1
Drew Lock
Under 10K tweets
2
Patriots
Under 10K tweets
3
Barry Melrose
Under 10K tweets
4
#AEWDynamite
Under 10K tweets
5
Cooper Kupp
Under 10K tweets
6
Josh McDaniels
Under 10K tweets
7
Seattle
Under 10K tweets
8
Eli Raridon
Under 10K tweets
9
Fetterman
Under 10K tweets
10
Milroe
Under 10K tweets

Most Popular Users

elonmusk's profile image
1
Elon Musk Verified account
@elonmusk
241.6M followers
barackobama's profile image
2
Barack Obama Verified account
@barackobama
119M followers
cristiano's profile image
3
Cristiano Ronaldo Verified account
@cristiano
114.2M followers
realdonaldtrump's profile image
4
Donald J. Trump Verified account
@realdonaldtrump
111.8M followers
narendramodi's profile image
5
Narendra Modi Verified account
@narendramodi
107.2M followers
rihanna's profile image
6
Rihanna Verified account
@rihanna
98.7M followers
nasa's profile image
7
NASA Verified account
@nasa
92.4M followers
justinbieber's profile image
8
Justin Bieber Verified account
@justinbieber
91.8M followers
katyperry's profile image
9
KATY PERRY Verified account
@katyperry
89.9M followers
taylorswift13's profile image
10
Taylor Swift Verified account
@taylorswift13
83.8M followers
ladygaga's profile image
11
Lady Gaga Verified account
@ladygaga
75.3M followers
imvkohli's profile image
12
Virat Kohli Verified account
@imvkohli
73.1M followers
kimkardashian's profile image
13
Kim Kardashian Verified account
@kimkardashian
70.8M followers
youtube's profile image
14
YouTube Verified account
@youtube
68.8M followers
neymarjr's profile image
15
Neymar Jr Verified account
@neymarjr
66.2M followers
billgates's profile image
16
Bill Gates Verified account
@billgates
65M followers
selenagomez's profile image
17
Selena Gomez Verified account
@selenagomez
62.9M followers
theellenshow's profile image
18
The Ellen Show
@theellenshow
62.3M followers
cnn's profile image
19
CNN Verified account
@cnn
61.8M followers
x's profile image
20
X Verified account
@x
60.7M followers